Serrapeptase

non-nutrient/non-botanical

What is it

Serrapeptase (also called serratiopeptidase) is a proteolytic enzyme originally isolated from bacteria in the gut of silkworms. It has been used in Japan and Europe for decades as an oral anti-inflammatory and to thin mucus, though clinical evidence quality is mixed.

How it works

Serrapeptase is a metalloprotease that breaks down proteins by cleaving specific peptide bonds. When taken orally on an empty stomach in enteric-coated form, a portion is absorbed intact through the intestinal wall and exerts systemic effects, primarily on inflammation, swelling, and abnormal protein deposits. Proposed mechanisms include breakdown of bradykinin and other inflammatory mediators, thinning of mucus by hydrolyzing its protein components, and dissolution of fibrin in scar tissue and blood clots. These actions theoretically support reduced swelling, easier mucus clearance, and improved tissue healing. Serrapeptase has been used clinically in Japan, Italy, and other countries since the 1950s. However, much of the original evidence comes from older or poorly controlled studies, and rigorous high-quality trials remain limited. Effects in well-designed Western trials have often been modest or inconsistent.

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Post-surgical swelling and pain

Grade C

Moderate evidence

Some studies, particularly from Japan and India, support serrapeptase for reducing swelling and pain after dental, ENT, and orthopedic surgery. Higher-quality Western trials have shown more modest or mixed results.

Chronic sinusitis / mucus thinning

Grade C

Moderate evidence

Older studies suggest serrapeptase may help thin mucus and improve symptoms in chronic sinusitis and bronchitis. Quality of evidence varies.

Fibrocystic breast disease

Grade C

Moderate evidence

A few small studies suggest possible benefit for breast pain and engorgement in fibrocystic breast disease, possibly through anti-inflammatory and fibrinolytic effects.

General inflammation / arthritis

Grade D

Mixed evidence

Marketing claims for arthritis and chronic inflammation outpace clinical evidence. Effects in rigorous trials have been small or inconsistent.

Scar tissue / arterial plaque

Grade F

Limited evidence

Popular claims that serrapeptase dissolves scar tissue or arterial plaque are not supported by human clinical evidence. Mostly extrapolation from lab data.

2 commercial forms

Enteric-coated serrapeptase

Enteric coating is essential to survive stomach acid and reach the intestine for absorption.

The standard supplement form. Activity expressed in serrapeptase units (SU).

High-activity serrapeptase (120,000+ SU)

Higher unit count per capsule for users wanting more concentrated doses.

Sometimes preferred for therapeutic-level use under medical guidance.

Dosage

Typical doses are 10-60 mg/day, often expressed in serrapeptase units (10,000-120,000 SU/day). Enteric coating is essential. Take on an empty stomach at least 30 minutes before meals or 2 hours after. No formal UL exists; doses up to 60 mg/day appear well-tolerated.

When and how to take it

Always take on an empty stomach (at least 30 minutes before meals or 2 hours after) to allow absorption rather than digestion of food proteins. Enteric coating is essential. Many users dose once or twice daily, often morning and evening before bed. Consistency matters more than exact timing.

Safety

Serrapeptase is generally well-tolerated. Side effects include GI upset, skin rash, and (rarely) allergic reactions or pneumonitis. It mildly thins blood and may increase bleeding risk, particularly with concurrent anticoagulants. Long-term safety data are limited but the enzyme has been used clinically for decades.

Who should be cautious

Avoid in bleeding disorders, active peptic ulcer, or before surgery (stop 2 weeks prior). Caution with anticoagulants and antiplatelet drugs. Avoid in pregnancy and lactation due to limited safety data. Caution in liver or kidney disease. Anyone with prior allergic reaction to silkworm-derived products should avoid.

Interactions

May potentiate anticoagulants and antiplatelet drugs (warfarin, aspirin, NSAIDs), raising bleeding risk. May enhance absorption of certain antibiotics. May interact with fibrinolytic drugs. Combining with other proteolytic enzymes is common.

Frequently asked questions

Does serrapeptase really work for inflammation?⌄

Older studies and decades of clinical use in Japan and Europe support modest anti-inflammatory effects. Higher-quality recent trials have shown more mixed or modest results. Effects vary by indication.

Why does it need to be enteric-coated?⌄

Serrapeptase is destroyed by stomach acid. Enteric coating delays release until the intestine, where it can be absorbed intact for systemic effects.

Can serrapeptase dissolve scar tissue or arterial plaque?⌄

Popular claims like these are not supported by clinical evidence. Most are extrapolations from laboratory studies and should be regarded with skepticism.

Is it safe with blood thinners?⌄

Serrapeptase mildly thins blood, so combining with anticoagulants or antiplatelets raises bleeding risk. Use only with prescriber oversight.

How long until I notice effects?⌄

For acute inflammation (post-surgical), days. For chronic conditions like sinusitis, 2-4 weeks. Stop if no benefit is apparent after a reasonable trial.

References

  • Serrapeptase - Wikidata — Wikidata link

Track Serrapeptase with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.